While the first treatment modality determined a slight increase of FXN mRNA and mitobiogenesis (as measured by mitochondrial DNA/nuclear DNA ratio), which did not reach statistical significance and yielded no improvement in behavioural tests, the second determined an improvement of motor function as assessed by rotarod performance test [ 123 ].
← all excerpts
Apparent Opportunities and Hidden Pitfalls: The Conflicting Results of Restoring NRF2-Regulated Redox Metabolism in Friedreich's Ataxia Pre-Clinical Models and Clinical Trials.
1
—
—